Follistatin-like 1 promotes proliferation of matured human hypoxic iPSC-cardiomyocytes and is secreted by cardiac fibroblasts
The human heart has limited regenerative capacity. Therefore, patients often progress to heart failure after ischemic injury, despite advances in reperfusion therapies generally decreasing mortality. Depending on its glycosylation state, Follistatin-like 1 (FSTL1) has been shown to increase cardiomy...
Main Authors: | , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado: |
Elsevier
2022-06-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Subjects: | |
Acceso en liña: | http://www.sciencedirect.com/science/article/pii/S2329050122000213 |